Annexin Pharmaceuticals AB (publ) (STO:ANNX)
Sweden flag Sweden · Delayed Price · Currency is SEK
15.00
+0.10 (0.67%)
Feb 11, 2026, 2:33 PM CET

STO:ANNX Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
10514023188154137
Market Cap Growth
-59.73%-39.44%161.10%-42.68%12.35%9.62%
Enterprise Value
7810320587117130
Last Close Price
14.9019.8042.2823.7555.2355.34
PB Ratio
4.225.6116.834.705.112.94
P/TBV Ratio
4.255.6417.174.795.202.97
Quick Ratio
5.325.323.153.035.058.33
Current Ratio
5.475.473.273.135.168.37
Return on Equity (ROE)
-190.93%-190.93%-308.99%-179.93%-105.95%-154.80%
Return on Assets (ROA)
-92.27%-92.27%-137.55%-86.77%-56.80%-84.72%
Return on Capital Employed (ROCE)
-145.60%-145.60%-367.50%-234.10%-134.80%-113.10%
Earnings Yield
-35.08%-26.40%-21.77%-49.84%-26.41%-37.99%
FCF Yield
-35.23%-26.51%-21.76%-49.10%-26.70%-32.81%
Buyback Yield / Dilution
-46.31%-46.31%-170.59%-14.23%-78.30%-33.40%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.